Pershing Square Sold Stake in Valeant

William Ackman ’s Pershing Square sold its stake in struggling drugmaker Valeant Pharmaceuticals, taking a roughly $4 billion loss and bringing to a close one of the most tortured sagas in hedge-fund history.

Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news